Market Closed -
Nyse
04:00:00 2024-04-19 pm EDT
5-day change
1st Jan Change
0.3992
USD
-4.04%
-8.67%
-29.98%
Senseonics Holdings, Inc.(NYSEAM:SENS) added to S&P Global BMI Index
September 20, 2021 at 12:00 am EDT
Senseonics Holdings, Inc.(NYSEAM:SENS) added to S&P Global BMI Index
Senseonics Holdings, Inc. Announces Board Changes
Mar. 25
CI
Transcript : Senseonics Holdings, Inc., Q4 2023 Earnings Call, Feb 29, 2024
Feb. 29
Senseonics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Feb. 29
CI
Senseonics Holdings, Inc. Provides Revenue Guidance for the First Half of 2024
Feb. 29
CI
Earnings Flash (SENS) SENSEONICS HOLDINGS Posts Q4 Revenue $8M, vs. Street Est of $7.6M
Feb. 29
MT
Senseonics Q4 Revenue Guidance Tops Consensus
Jan. 02
MT
Earnings Flash (SENS) SENSEONICS HOLDINGS Reports Q3 Revenue $6.1M, vs. Street Est of $5.5M
Nov. 09
MT
Senseonics Holdings, Inc. Provides Earnings Guidance for the Year 2023
Nov. 09
CI
Transcript : Senseonics Holdings, Inc., Q3 2023 Earnings Call, Nov 09, 2023
Nov. 09
Senseonics Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 09
CI
Senseonics Holdings, Inc. Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study
23-09-26
CI
Senseonics Holdings, Inc.(NYSEAM:SENS) dropped from S&P Healthcare Equipment Select Industry Index
23-09-18
CI
Senseonics Holdings, Inc. Enters into $50 Million Loan Facility with Hercules Capital, Inc
23-09-11
CI
Senseonics Holdings, Inc. announced that it expects to receive $50 million in funding
23-09-07
CI
Insider Buy: Senseonics Holdings
23-08-31
MT
HC Wainwright Adjusts Senseonics Price Target to $2 From $3, Maintains Buy Rating
23-08-15
MT
Senseonics Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-10
CI
Transcript : Senseonics Holdings, Inc., Q2 2023 Earnings Call, Aug 10, 2023
23-08-10
Senseonics Holdings, Inc. Reiterates Revenue Guidance for the Full Year 2023
23-08-10
CI
Earnings Flash (SENS) SENSEONICS HOLDINGS Reports Q2 Revenue $4.1M, vs. Street Est of $4.49M
23-08-10
MT
Jefferies Starts Senseonics Holdings at Underperform With $0.50 Price Target
23-07-19
MT
Sensonics Holdings, Inc. Announces New Clinical Data Demonstrating the Safety and Accuracy of Eversense Through 365 Days Presented at the American Diabetes Association 83rd Scientific Sessions
23-06-26
CI
Senseonics Holdings, Inc.(NYSEAM:SENS) dropped from Russell 3000 Index
23-06-23
CI
Senseonics Holdings, Inc.(NYSEAM:SENS) dropped from Russell 3000E Growth Index
23-06-23
CI
Senseonics Holdings, Inc.(NYSEAM:SENS) dropped from Russell 3000E Index
23-06-23
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems, Eversense, Eversense XL, and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every five minutes to a mobile app on the user's smartphone. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device. Its CGM system continually and accurately measures a person's glucose levels for up to six months.
More about the company
Last Close Price
0.416
USD
Average target price
1.633
USD
Spread / Average Target
+292.63%
Consensus
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
SENSEONICS HOLDINGS, INC. 
